Abstract
Glutamic oxalacetic aminopherase (transaminase) is widely distributed in animal tissues. Its greatest activity has been found in homogenates of heart muscle, skeletal muscle, brain, liver, and kidney, in decreasing order. This enzyme activity has been found in all animal and human serums tested, and the activities are comparable whether the analysis is done chromatographically or spectrophotometrically. It has been demonstrated that serum glutamic oxalacetic aminopherase activity increases 2 to 20 times normal after acute myocardial infarction and may rise 20 to 100 times normal in hepatitis due to toxic or infectious agents. The present study is an extension of a preliminary report on serum glutamic oxalacetic aminopherase alterations in liver disease, with particular emphasis on hepatitis. The study to be reported will describe the activity in hepatitis and discuss the usefulness of determination of the activity in the diagnosis and management of hepatitis and in the epidemiological course of infectious
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.